P.D. Soros Fellowship for New Americans


Kingson Lin, 2022

MD/PhD, Yale University

Kingson Lin is the child of immigrants from China

Fellowship awarded to support work towards an MD/PhD in Medicine and Experimental Pathology at Yale University

Kingson Lin was born in New York City to immigrant parents from the rural fishing providence of Fujian, China. However, shortly after his birth, he was brought to Fujian to live with his grandparents. Growing up in Fujian, Kingson only heard tales of America through phone calls with his mother and through cartoons depictions on TV. After five years away, Kingson was finally able to see America through his own eyes when he flew to JFK to be reunited with his parents. Kingson spent his first few years in the bustling ethnic enclave of Flushing, Queens before moving to the suburbs of Philadelphia.

Kingson attended the University of Pennsylvania as a first-generation, low-income (FGLI) student and participated in the PENNCAP Pre-freshman Program with other incoming Penn students from non-traditional backgrounds. At Penn, Kingson deepened his passion for chemistry and performed pioneering research in the laboratory of Professor Gary Molander on a novel paradigm for organic synthesis utilizing photoredox/nickel dual catalysis to make previously difficult chemical bonds with widespread potential applications ranging from basic science to the pharmaceutical industry. His work has been published in ACS Catalysis and Organic Syntheses.

At Penn, Kingson also developed a passion for tutoring and mentorship with a desire to pay forward the mentorship and support he has received on his journey. Kingson served as a tutor, residential advisor, freshmen mentor, and peer counselor for the PPENNCAP program. Kingson graduated from Penn with a BA in biochemistry, minor in Spanish, and a MS in organic chemistry.

After graduating summa cum laude, Phi Beta Kappa, and Sigma Xi, Kingson entered the MD/PhD Program at Yale University. Kingson is currently completing his doctoral work under the mentorship of Professors Ranjit Bindra and Seth Herzon. He is researching the design, synthesis, and evaluation of novel chemotherapeutics for drug resistant brain cancers. In parallel, Kingson has also cofounded a company with his mentors to rapidly translate the significant results of his research to a clinical candidate for relapsed, refractory patients.

  • BA Biochemistry | University of Pennsylvania 2017
  • MS Chemistry | University of Pennsylvania 2017
  • MD Medicine | Yale University
  • PhD Experimental Pathology | Yale University
Related Articles

The Opportunity You Shouldn't Pass Up: Apply

The 2025 application is open. Are you a New American who will be 30 or younger as of October 31, 2024, and who will be in graduate school full-time for the 2025-2026 academic year? Check out our eligibility requirements, learn about the Fellowships,...

Read More
transform="translate(188.000000, 15.000000)"